Journal
CELL
Volume 141, Issue 7, Pages 1117-1134Publisher
CELL PRESS
DOI: 10.1016/j.cell.2010.06.011
Keywords
-
Categories
Funding
- NIH [R01-AR051448, R01-AR051886, P50-AR054086, R01-CA079992, R01-CA096768, R01-CA125432]
Ask authors/readers for more resources
Recent structural studies of receptor tyrosine kinases (RTKs) have revealed unexpected diversity in the mechanisms of their activation by growth factor ligands. Strategies for inducing dimerization by ligand binding are surprisingly diverse, as are mechanisms that couple this event to activation of the intracellular tyrosine kinase domains. As our understanding of these details becomes increasingly sophisticated, it provides an important context for therapeutically countering the effects of pathogenic RTK mutations in cancer and other diseases. Much remains to be learned, however, about the complex signaling networks downstream from RTKs and how alterations in these networks are translated into cellular responses.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available